CFG
GSK icon

Citizens Financial Group’s GSK GSK Stock Holding History

Citizens Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-321
Closed -$19K – 1155
2019
Q4 		$19K Sell
321
-127
-28% -$7.06K ﹤0.01% 626
2019
Q3 		$24K Buy
448
+256
+133% +$13.2K ﹤0.01% 445
2019
Q2 		$10K Buy
+192
New +$9.63K ﹤0.01% 552
2017
Q3 		– Sell
-86
Closed -$5K – 520
2017
Q2 		$5K Sell
86
-709
-89% -$37.8K ﹤0.01% 463
2017
Q1 		$41K Sell
795
-341
-30% -$17.3K ﹤0.01% 363
2016
Q4 		$55K Sell
1,136
-3
-0.3% -$148 0.01% 339
2016
Q3 		$62K Sell
1,139
-208
-15% -$11.4K 0.01% 340
2016
Q2 		$73K Sell
1,347
-428
-24% -$22.5K 0.01% 330
2016
Q1 		$90K Sell
1,775
-160
-8% -$7.97K 0.01% 307
2015
Q4 		$97K Buy
+1,935
New +$98.6K 0.01% 306

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Citizens Financial Group's GSK Position: Q1 2020 in Review

Citizens Financial Group sold out of GSK (GSK) in Q1 2020, closing a stake of 321 shares — an estimated $19K sold.

Citizens Financial Group first reported a position in GSK in Q4 2015 and held it in 10 quarters. The position peaked at $97K in Q4 2015. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Citizens Financial Group reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Citizens Financial Group sold 321 GSK shares in Q1 2020, an estimated $19K.
  • Citizens Financial Group first reported a position in GSK in Q4 2015 and held it in 10 quarters.
  • Citizens Financial Group's GSK position peaked at $97K in Q4 2015.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Citizens Financial Group's 13F filing for Q1 2020, filed 8 May 2020.